Detalhe da pesquisa
1.
Phenotypic characterization of disease-initiating stem cells in JAK2- or CALR-mutated myeloproliferative neoplasms.
Am J Hematol
; 98(5): 770-783, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36814396
2.
Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with NPM1-mutated AML: results from the AMLSG 09-09 trial.
Blood
; 136(26): 3041-3050, 2020 12 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33367545
3.
Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study Group.
Blood
; 134(19): 1608-1618, 2019 11 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31554635
4.
Presence of viremia during febrile neutropenic episodes in patients undergoing chemotherapy for malignant neoplasms.
Am J Hematol
; 96(6): 719-726, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33784434
5.
CGRP Signaling via CALCRL Increases Chemotherapy Resistance and Stem Cell Properties in Acute Myeloid Leukemia.
Int J Mol Sci
; 20(23)2019 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31756985
6.
High-dose Bendamustine-EAM followed by autologous stem cell rescue results in long-term remission rates in lymphoma patients, without renal toxicity.
Eur J Haematol
; 101(3): 326-331, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29799642
7.
Valproic acid in combination with all-trans retinoic acid and intensive therapy for acute myeloid leukemia in older patients.
Blood
; 123(26): 4027-36, 2014 Jun 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-24797300
8.
Salvage therapy with high-dose cytarabine and mitoxantrone in combination with all-trans retinoic acid and gemtuzumab ozogamicin in acute myeloid leukemia refractory to first induction therapy.
Haematologica
; 101(7): 839-45, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27036160
9.
Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09-09): a randomised, open-label, multicentre, phase 3 trial.
Lancet Haematol
; 10(7): e495-e509, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37187198
10.
Clinical significance of genetic aberrations in secondary acute myeloid leukemia.
Am J Hematol
; 87(11): 1010-6, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22887079
11.
CPX-351 (Vyxeos®) can cause severe rash in acute myeloid leukemia-A case report.
Clin Case Rep
; 9(4): 1933-1936, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33936618
12.
IL2RA Promotes Aggressiveness and Stem Cell-Related Properties of Acute Myeloid Leukemia.
Cancer Res
; 80(20): 4527-4539, 2020 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32873636
13.
Genomic heterogeneity in core-binding factor acute myeloid leukemia and its clinical implication.
Blood Adv
; 4(24): 6342-6352, 2020 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33351131
14.
Gemtuzumab Ozogamicin in NPM1-Mutated Acute Myeloid Leukemia: Early Results From the Prospective Randomized AMLSG 09-09 Phase III Study.
J Clin Oncol
; 38(6): 623-632, 2020 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31851556
15.
Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98B.
Haematologica
; 94(1): 54-60, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19059939
16.
Expression and prognostic significance of different mRNA 5'-end variants of the oncogene EVI1 in 266 patients with de novo AML: EVI1 and MDS1/EVI1 overexpression both predict short remission duration.
Genes Chromosomes Cancer
; 47(4): 288-98, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18181178
17.
All-trans retinoic acid enhances, and a pan-RAR antagonist counteracts, the stem cell promoting activity of EVI1 in acute myeloid leukemia.
Cell Death Dis
; 10(12): 944, 2019 12 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31822659
18.
Oxidation by hypochlorite converts protective HDL into a potent platelet agonist.
FEBS Lett
; 582(5): 778-84, 2008 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-18267121
19.
Platelet-stimulating effects of oxidized LDL are not attributable to toxic properties of the lipoproteins.
Thromb Res
; 122(5): 630-9, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18387657
20.
Hypochlorite-oxidized low density lipoproteins reduce production and bioavailability of nitric oxide in RAW 264.7 macrophages by distinct mechanisms.
Life Sci
; 83(1-2): 50-8, 2008 Jul 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-18558412